Chew Jing Ming, CEO and co-founder of Auristone
Singapore-based epigenomic (the science of how genes are expressed) research and innovation company Auristone has announced the completion of its US$4 million seed funding round, led by Elev8.vc.
SEEDS Capital and Genedant also participated.
Also Read: ‘We aim to make early cancer detection accessible on a global scale’: Mirxes CEO
This infusion of capital will be strategically deployed to enhance Auristone’s capabilities through clinical collaborations and to drive market adoption of its flagship molecular profiling test, EPI-CALL, by working closely with regional genomic companies.
Auristone harnesses the power of epigenomic insights to transform the field of precision medicine. Using epigenomics, Auristone can predict patients’ likelihood of response to different treatment options, helping doctors determine patient treatment plans.
EPI-CALL is designed to help doctors and patients navigate the complexities of therapy selection for late-stage cancer patients.
Auristone’s other products are Signomax (a sample-to-report ChIP-Seq and RNA-Seq service to support research endeavours) and EPI-Tome (an epigenomic-driven novel biomarker and drug discovery engine).
Also Read: Harnessing the power of AI to help improve gastric cancer detection
“In order to continually deliver value for the community, we will partner with regional genomic companies to offer EPI-CALL and deepen clinical collaborations to gain new epigenomic insights,” said Chew Jing Ming, CEO and co-founder of Auristone.
—
X marks Echelon. Join us at Singapore EXPO on May 15-16 for the 10th edition of Asia’s leading tech and startup conference. Enjoy 2 days of building connections with potential investors, partners, and customers, exploring innovation, and sharing insights with 8,000+ key decision-makers of Asia’s tech ecosystem. Get your tickets here.
Want more from your Echelon experience? Be an Echelon X sponsor or exhibitor. Send enquiry here.
The post Auristone aims to transform precision medicine field with US$4M funding appeared first on e27.